A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v2; ref status: indexed, http://f1000r.es/4wt]

A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus [v2; ref status: indexed, http://f1000r.es/4wt]

We are currently faced with a global infectious disease crisis which has been anticipated for decades. While many promising biotherapeutics are being tested, the search for a small molecule has yet to deliver an approved drug or therapeutic for the Ebola or similar filoviruses that cause haemorrhagi...

Full description

Bibliographic Details
Main Authors: Sean Ekins, Joel S. Freundlich, Megan Coffee
Format: Article
Language:English
Published: F1000 Research Ltd 2014-12-01
Series:F1000Research
Subjects:
Antimicrobials & Drug Resistance
Biomacromolecule-Ligand Interactions
Drug Discovery & Design
Medical Microbiology
Tropical & Travel-Associated Diseases
Virology
Online Access:http://f1000research.com/articles/3-277/v2

Internet

http://f1000research.com/articles/3-277/v2

Similar Items